

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 7.55305262 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 7.36651123 |
| 3 | lymphangiogenesis (GO:0001946) | 6.08491086 |
| 4 | endothelium development (GO:0003158) | 6.04052853 |
| 5 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.99054386 |
| 6 | heart trabecula formation (GO:0060347) | 5.32728890 |
| 7 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.19134833 |
| 8 | surfactant homeostasis (GO:0043129) | 5.11648551 |
| 9 | blood vessel maturation (GO:0001955) | 5.10777701 |
| 10 | positive regulation of vasculogenesis (GO:2001214) | 5.09766826 |
| 11 | morphogenesis of an endothelium (GO:0003159) | 4.96220533 |
| 12 | endothelial tube morphogenesis (GO:0061154) | 4.96220533 |
| 13 | regulation of endothelial cell differentiation (GO:0045601) | 4.91507822 |
| 14 | regulation of vasculogenesis (GO:2001212) | 4.55177761 |
| 15 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.52369903 |
| 16 | sprouting angiogenesis (GO:0002040) | 4.42845093 |
| 17 | endothelial cell morphogenesis (GO:0001886) | 4.39918910 |
| 18 | glomerular filtration (GO:0003094) | 4.21939274 |
| 19 | tooth mineralization (GO:0034505) | 4.19164651 |
| 20 | blood vessel endothelial cell migration (GO:0043534) | 4.05937273 |
| 21 | chemical homeostasis within a tissue (GO:0048875) | 4.03220640 |
| 22 | renal filtration (GO:0097205) | 4.02585430 |
| 23 | endothelial cell differentiation (GO:0045446) | 3.99728963 |
| 24 | basement membrane organization (GO:0071711) | 3.94184381 |
| 25 | patterning of blood vessels (GO:0001569) | 3.88117659 |
| 26 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.82713222 |
| 27 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.82713222 |
| 28 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.81303667 |
| 29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.76548059 |
| 30 | ovulation from ovarian follicle (GO:0001542) | 3.71940414 |
| 31 | transcytosis (GO:0045056) | 3.67325958 |
| 32 | venous blood vessel morphogenesis (GO:0048845) | 3.61320466 |
| 33 | trabecula formation (GO:0060343) | 3.58191459 |
| 34 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.51371901 |
| 35 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.50335279 |
| 36 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.44867253 |
| 37 | negative regulation of type 2 immune response (GO:0002829) | 3.43629784 |
| 38 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.43576300 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41468260 |
| 40 | cardiac myofibril assembly (GO:0055003) | 3.40076298 |
| 41 | endothelial cell proliferation (GO:0001935) | 3.38220354 |
| 42 | negative regulation of endothelial cell migration (GO:0010596) | 3.35323245 |
| 43 | endothelial cell chemotaxis (GO:0035767) | 3.34461147 |
| 44 | vasculogenesis (GO:0001570) | 3.34068776 |
| 45 | positive regulation of cell junction assembly (GO:1901890) | 3.29500564 |
| 46 | positive regulation of focal adhesion assembly (GO:0051894) | 3.29500564 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.28407080 |
| 48 | plasma membrane repair (GO:0001778) | 3.25874488 |
| 49 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.25319706 |
| 50 | regulation of vascular permeability (GO:0043114) | 3.22861063 |
| 51 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.18716650 |
| 52 | sarcomere organization (GO:0045214) | 3.18609847 |
| 53 | regulation of sequestering of triglyceride (GO:0010889) | 3.15725451 |
| 54 | protein heterotrimerization (GO:0070208) | 3.15535126 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.13818095 |
| 56 | triglyceride catabolic process (GO:0019433) | 3.13015469 |
| 57 | positive regulation of adherens junction organization (GO:1903393) | 3.10679175 |
| 58 | establishment of endothelial barrier (GO:0061028) | 3.10462727 |
| 59 | endothelial cell migration (GO:0043542) | 3.06857974 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 3.06781761 |
| 61 | embryonic heart tube development (GO:0035050) | 3.05934009 |
| 62 | negative regulation of vascular permeability (GO:0043116) | 3.04677154 |
| 63 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.99197925 |
| 64 | lung vasculature development (GO:0060426) | 2.96484026 |
| 65 | fatty acid transmembrane transport (GO:1902001) | 2.96231042 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 2.94373498 |
| 67 | positive regulation of receptor recycling (GO:0001921) | 2.94138597 |
| 68 | myofibril assembly (GO:0030239) | 2.93240031 |
| 69 | blood vessel remodeling (GO:0001974) | 2.92731967 |
| 70 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.91628940 |
| 71 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.89106065 |
| 72 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.85017546 |
| 73 | negative regulation of platelet activation (GO:0010544) | 2.84577108 |
| 74 | cell migration involved in heart development (GO:0060973) | 2.84418882 |
| 75 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.84068165 |
| 76 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.80482644 |
| 77 | negative regulation of epithelial cell migration (GO:0010633) | 2.79472899 |
| 78 | acylglycerol catabolic process (GO:0046464) | 2.78804920 |
| 79 | neutral lipid catabolic process (GO:0046461) | 2.78804920 |
| 80 | regulation of endothelial cell migration (GO:0010594) | 2.76756075 |
| 81 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.75660107 |
| 82 | regulation of p38MAPK cascade (GO:1900744) | 2.73021638 |
| 83 | coronary vasculature morphogenesis (GO:0060977) | 2.72859428 |
| 84 | axon extension involved in axon guidance (GO:0048846) | 2.72491227 |
| 85 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.72491227 |
| 86 | blood vessel morphogenesis (GO:0048514) | 2.71479628 |
| 87 | cardiac muscle cell proliferation (GO:0060038) | 2.69885547 |
| 88 | regulation of endothelial cell proliferation (GO:0001936) | 2.68371585 |
| 89 | trabecula morphogenesis (GO:0061383) | 2.68244459 |
| 90 | * cAMP biosynthetic process (GO:0006171) | 2.68002173 |
| 91 | positive regulation of endothelial cell migration (GO:0010595) | 2.67978362 |
| 92 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.67634409 |
| 93 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.67114304 |
| 94 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.66298510 |
| 95 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.66284688 |
| 96 | cGMP-mediated signaling (GO:0019934) | 2.66027911 |
| 97 | angiogenesis involved in wound healing (GO:0060055) | 2.62158667 |
| 98 | substrate-dependent cell migration (GO:0006929) | 2.61269294 |
| 99 | regulation of cardioblast differentiation (GO:0051890) | 2.60710385 |
| 100 | regulation of actin filament-based movement (GO:1903115) | 2.60478296 |
| 101 | negative regulation of angiogenesis (GO:0016525) | 2.60238027 |
| 102 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.59158106 |
| 103 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.59074395 |
| 104 | regulation of relaxation of muscle (GO:1901077) | 2.56777434 |
| 105 | positive regulation of protein kinase C signaling (GO:0090037) | 2.55837117 |
| 106 | carnitine shuttle (GO:0006853) | 2.55229312 |
| 107 | heterotypic cell-cell adhesion (GO:0034113) | 2.54619832 |
| 108 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52792833 |
| 109 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.52359038 |
| 110 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.49439719 |
| 111 | heart trabecula morphogenesis (GO:0061384) | 2.49066116 |
| 112 | response to epinephrine (GO:0071871) | 2.48782173 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48749572 |
| 114 | regulation of cholesterol storage (GO:0010885) | 2.48727083 |
| 115 | positive regulation of p38MAPK cascade (GO:1900745) | 2.47789314 |
| 116 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.47534234 |
| 117 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.46358159 |
| 118 | muscle filament sliding (GO:0030049) | 2.46040899 |
| 119 | actin-myosin filament sliding (GO:0033275) | 2.46040899 |
| 120 | actomyosin structure organization (GO:0031032) | 2.45903137 |
| 121 | gap junction assembly (GO:0016264) | 2.45776125 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 2.45751382 |
| 123 | negative regulation of vasculature development (GO:1901343) | 2.45585385 |
| 124 | barbed-end actin filament capping (GO:0051016) | 2.45340039 |
| 125 | angiogenesis (GO:0001525) | 2.45235830 |
| 126 | negative regulation of protein autophosphorylation (GO:0031953) | 2.41843270 |
| 127 | positive regulation of protein sumoylation (GO:0033235) | 2.39691555 |
| 128 | hyaluronan catabolic process (GO:0030214) | 2.39227640 |
| 129 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.37834434 |
| 130 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.32171823 |
| 131 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.31857017 |
| 132 | mannose metabolic process (GO:0006013) | 2.28401917 |
| 133 | extracellular matrix assembly (GO:0085029) | 2.26033723 |
| 134 | phagocytosis, recognition (GO:0006910) | 2.22708486 |
| 135 | polyol transport (GO:0015791) | 2.22330580 |
| 136 | diacylglycerol metabolic process (GO:0046339) | 2.21036324 |
| 137 | actin-mediated cell contraction (GO:0070252) | 2.20555034 |
| 138 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.19445921 |
| 139 | cardiac muscle contraction (GO:0060048) | 2.17745056 |
| 140 | * activation of protein kinase A activity (GO:0034199) | 2.17735697 |
| 141 | positive regulation of odontogenesis (GO:0042482) | 2.14124171 |
| 142 | germinal center formation (GO:0002467) | 2.13488583 |
| 143 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.12462433 |
| 144 | regulation of type 2 immune response (GO:0002828) | 2.12446958 |
| 145 | lipid storage (GO:0019915) | 2.09154907 |
| 146 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.09115516 |
| 147 | positive regulation of steroid hormone secretion (GO:2000833) | 2.09095248 |
| 148 | keratan sulfate catabolic process (GO:0042340) | 2.08559691 |
| 149 | response to dietary excess (GO:0002021) | 2.08265858 |
| 150 | positive regulation of cholesterol efflux (GO:0010875) | 2.08200902 |
| 151 | atrioventricular valve morphogenesis (GO:0003181) | 2.07538464 |
| 152 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.06994798 |
| 153 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.06994798 |
| 154 | cardiac muscle hypertrophy (GO:0003300) | 2.06282830 |
| 155 | detection of other organism (GO:0098543) | 2.05828496 |
| 156 | fibril organization (GO:0097435) | 2.03013509 |
| 157 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.02098108 |
| 158 | stress fiber assembly (GO:0043149) | 1.99892420 |
| 159 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 1.99433283 |
| 160 | endocrine hormone secretion (GO:0060986) | 1.99084671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16819736 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.60764676 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.54539265 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.37991006 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.36527354 |
| 6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.15859015 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.07076340 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.66715109 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43454028 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37954764 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35871154 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34670275 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.32009707 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28489047 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23355517 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.16773804 |
| 17 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15971001 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12930039 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12889595 |
| 20 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.12779096 |
| 21 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.12779096 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02275987 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00176787 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96771753 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92851642 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.91374078 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87431578 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85733511 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.76982152 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75912382 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.72545164 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68744444 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65797920 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63028475 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.60935350 |
| 36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56514756 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50691697 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.49886430 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49079922 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47514486 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46435661 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32855381 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29391198 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28757079 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28407645 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27701702 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27252849 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24322774 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21016400 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19026643 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18771335 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18617475 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18085467 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16711714 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15948644 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15868928 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15404215 |
| 58 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13739401 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13113599 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12571908 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12174470 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10969721 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09854734 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08925498 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08764059 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08542046 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07860286 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07202245 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06980736 |
| 70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06764832 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05651905 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05077350 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04914406 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04242736 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04103475 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04005628 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03964100 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03856561 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03236342 |
| 80 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03234597 |
| 81 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.02930720 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01955907 |
| 83 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01287095 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00918976 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00436742 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00397725 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99722259 |
| 88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99142739 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98462611 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97945400 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97699152 |
| 92 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.97667329 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97476997 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96924403 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96781807 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96751086 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96296693 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96239774 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96239774 |
| 100 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95283647 |
| 101 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95283647 |
| 102 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95262619 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94910742 |
| 104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94822931 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94439633 |
| 106 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94044144 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93635351 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93182318 |
| 109 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92949514 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92486343 |
| 111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92139835 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90839474 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90443522 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90335568 |
| 115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.90074883 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89938651 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89756627 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89645024 |
| 119 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89602439 |
| 120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89339474 |
| 121 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88983694 |
| 122 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88591501 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87786387 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87255331 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86989462 |
| 126 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86607973 |
| 127 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86217756 |
| 128 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.85795722 |
| 129 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85716476 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85495185 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84986815 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84859969 |
| 133 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84436102 |
| 134 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83472023 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83071303 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83071303 |
| 137 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82873021 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82646611 |
| 139 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81856391 |
| 140 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.79021435 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78401886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.78634833 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 5.26215938 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 4.45039787 |
| 4 | MP0004272_abnormal_basement_membrane | 3.72836812 |
| 5 | MP0003724_increased_susceptibility_to | 3.65896231 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.47993801 |
| 7 | MP0006054_spinal_hemorrhage | 2.88290793 |
| 8 | MP0003828_pulmonary_edema | 2.74000922 |
| 9 | MP0006138_congestive_heart_failure | 2.66388778 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.59958459 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.31981124 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.28147857 |
| 13 | MP0000751_myopathy | 2.27882822 |
| 14 | MP0005385_cardiovascular_system_phenoty | 1.98268568 |
| 15 | MP0001544_abnormal_cardiovascular_syste | 1.98268568 |
| 16 | MP0000767_abnormal_smooth_muscle | 1.96894765 |
| 17 | MP0000013_abnormal_adipose_tissue | 1.94078640 |
| 18 | MP0005330_cardiomyopathy | 1.93982986 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.93022029 |
| 20 | MP0002933_joint_inflammation | 1.91879990 |
| 21 | MP0005670_abnormal_white_adipose | 1.91816923 |
| 22 | MP0003279_aneurysm | 1.88761643 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.86314856 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.85137015 |
| 25 | MP0004130_abnormal_muscle_cell | 1.75005573 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.74932236 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.69494636 |
| 28 | MP0004484_altered_response_of | 1.67959090 |
| 29 | MP0000343_altered_response_to | 1.66643134 |
| 30 | MP0008961_abnormal_basal_metabolism | 1.65927642 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.64229447 |
| 32 | MP0005165_increased_susceptibility_to | 1.63320213 |
| 33 | MP0002971_abnormal_brown_adipose | 1.53899498 |
| 34 | MP0001958_emphysema | 1.53241866 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.52242029 |
| 36 | MP0000249_abnormal_blood_vessel | 1.49208987 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.49111139 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.47808252 |
| 39 | MP0002128_abnormal_blood_circulation | 1.45761983 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.43695237 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.43675860 |
| 42 | MP0000749_muscle_degeneration | 1.40867162 |
| 43 | MP0005595_abnormal_vascular_smooth | 1.37609303 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.37391811 |
| 45 | MP0004085_abnormal_heartbeat | 1.30849052 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.28535410 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.27324874 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.24998035 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.24170004 |
| 50 | MP0002925_abnormal_cardiovascular_devel | 1.23976582 |
| 51 | MP0003646_muscle_fatigue | 1.22226951 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.21194365 |
| 53 | MP0008004_abnormal_stomach_pH | 1.20024733 |
| 54 | MP0001614_abnormal_blood_vessel | 1.18847118 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.17540838 |
| 56 | MP0003436_decreased_susceptibility_to | 1.14181361 |
| 57 | MP0009115_abnormal_fat_cell | 1.13697853 |
| 58 | MP0005360_urolithiasis | 1.12046286 |
| 59 | MP0001851_eye_inflammation | 1.09725132 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.09046772 |
| 61 | MP0005275_abnormal_skin_tensile | 1.09023059 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.08622827 |
| 63 | MP0002419_abnormal_innate_immunity | 1.07834196 |
| 64 | MP0000266_abnormal_heart_morphology | 1.06788908 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.06387634 |
| 66 | MP0004510_myositis | 1.05054110 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.03571544 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.03492400 |
| 69 | MP0002106_abnormal_muscle_physiology | 1.01300056 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.98974419 |
| 71 | MP0003303_peritoneal_inflammation | 0.98347324 |
| 72 | MP0005164_abnormal_response_to | 0.97356900 |
| 73 | MP0005448_abnormal_energy_balance | 0.96579088 |
| 74 | MP0003690_abnormal_glial_cell | 0.96255233 |
| 75 | MP0001915_intracranial_hemorrhage | 0.95961725 |
| 76 | MP0004883_abnormal_blood_vessel | 0.95899418 |
| 77 | MP0005334_abnormal_fat_pad | 0.95755531 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.93408578 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 0.93201826 |
| 80 | MP0005535_abnormal_body_temperature | 0.91665571 |
| 81 | MP0004147_increased_porphyrin_level | 0.91587528 |
| 82 | MP0009278_abnormal_bone_marrow | 0.90769054 |
| 83 | MP0005369_muscle_phenotype | 0.90745440 |
| 84 | MP0005390_skeleton_phenotype | 0.90188610 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.89982030 |
| 86 | MP0001790_abnormal_immune_system | 0.89792226 |
| 87 | MP0005387_immune_system_phenotype | 0.89792226 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.88612840 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.84625916 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.84625916 |
| 91 | MP0009785_altered_susceptibility_to | 0.83268106 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.83216509 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.82573660 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.82486584 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.82443014 |
| 96 | MP0000747_muscle_weakness | 0.82416039 |
| 97 | MP0005025_abnormal_response_to | 0.82364737 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.80059835 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.79357205 |
| 100 | MP0001542_abnormal_bone_strength | 0.78731829 |
| 101 | MP0005365_abnormal_bile_salt | 0.78289287 |
| 102 | MP0001784_abnormal_fluid_regulation | 0.77730307 |
| 103 | MP0009697_abnormal_copulation | 0.77484482 |
| 104 | MP0002139_abnormal_hepatobiliary_system | 0.77069504 |
| 105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76319279 |
| 106 | MP0003091_abnormal_cell_migration | 0.76107859 |
| 107 | MP0003075_altered_response_to | 0.75898241 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.74952794 |
| 109 | MP0005388_respiratory_system_phenotype | 0.73450477 |
| 110 | MP0002133_abnormal_respiratory_system | 0.73450477 |
| 111 | MP0005409_darkened_coat_color | 0.68877520 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.66539222 |
| 113 | MP0003252_abnormal_bile_duct | 0.66381815 |
| 114 | MP0005083_abnormal_biliary_tract | 0.63635753 |
| 115 | MP0009764_decreased_sensitivity_to | 0.63189521 |
| 116 | MP0000733_abnormal_muscle_development | 0.62510308 |
| 117 | MP0005187_abnormal_penis_morphology | 0.60335792 |
| 118 | MP0002269_muscular_atrophy | 0.59824699 |
| 119 | MP0005503_abnormal_tendon_morphology | 0.59665054 |
| 120 | MP0009840_abnormal_foam_cell | 0.59314579 |
| 121 | MP0005023_abnormal_wound_healing | 0.57229967 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.56806152 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.56614137 |
| 124 | MP0003385_abnormal_body_wall | 0.56504852 |
| 125 | MP0003045_fibrosis | 0.56155139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polycythemia (HP:0001901) | 5.65730125 |
| 2 | Spontaneous hematomas (HP:0007420) | 4.72291573 |
| 3 | Ventricular tachycardia (HP:0004756) | 4.64969427 |
| 4 | Hematochezia (HP:0002573) | 4.56424044 |
| 5 | Sudden death (HP:0001699) | 4.47441675 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.41468867 |
| 7 | Nonimmune hydrops fetalis (HP:0001790) | 4.40031051 |
| 8 | Broad metatarsal (HP:0001783) | 4.33211943 |
| 9 | Esophageal varix (HP:0002040) | 4.28885519 |
| 10 | Increased connective tissue (HP:0009025) | 3.99875788 |
| 11 | Lymphangioma (HP:0100764) | 3.80895965 |
| 12 | Atrial fibrillation (HP:0005110) | 3.80290635 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 3.75905042 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.70090530 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 3.58064708 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.56270575 |
| 17 | Overgrowth (HP:0001548) | 3.55934527 |
| 18 | Primary atrial arrhythmia (HP:0001692) | 3.50844655 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 3.47737870 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.42497777 |
| 21 | Supraventricular tachycardia (HP:0004755) | 3.33705865 |
| 22 | Lipoatrophy (HP:0100578) | 3.30915150 |
| 23 | Cerebral hemorrhage (HP:0001342) | 3.27414500 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 3.08543417 |
| 25 | Difficulty running (HP:0009046) | 3.07823776 |
| 26 | Round ear (HP:0100830) | 3.05610732 |
| 27 | Cervical subluxation (HP:0003308) | 2.94642645 |
| 28 | Visceral angiomatosis (HP:0100761) | 2.93590589 |
| 29 | Conjunctival telangiectasia (HP:0000524) | 2.92013541 |
| 30 | Exercise-induced myalgia (HP:0003738) | 2.82539999 |
| 31 | Mesangial abnormality (HP:0001966) | 2.76700307 |
| 32 | Dilated cardiomyopathy (HP:0001644) | 2.73508471 |
| 33 | Hemangiomatosis (HP:0007461) | 2.72267104 |
| 34 | Calf muscle hypertrophy (HP:0008981) | 2.70985487 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.69321067 |
| 36 | Hypoglycemic coma (HP:0001325) | 2.68844864 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.64494483 |
| 38 | Atrioventricular block (HP:0001678) | 2.58273472 |
| 39 | Syncope (HP:0001279) | 2.58117059 |
| 40 | Abnormality of complement system (HP:0005339) | 2.57594632 |
| 41 | Cavernous hemangioma (HP:0001048) | 2.56054008 |
| 42 | Hypertriglyceridemia (HP:0002155) | 2.56035768 |
| 43 | Myoglobinuria (HP:0002913) | 2.55487393 |
| 44 | Hypoplastic ischia (HP:0003175) | 2.54967104 |
| 45 | Aneurysm (HP:0002617) | 2.54951242 |
| 46 | Joint hemorrhage (HP:0005261) | 2.54516993 |
| 47 | Joint stiffness (HP:0001387) | 2.54400814 |
| 48 | EMG: myopathic abnormalities (HP:0003458) | 2.53389663 |
| 49 | Abnormality of the calf musculature (HP:0001430) | 2.52474333 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50673268 |
| 51 | Protrusio acetabuli (HP:0003179) | 2.48921931 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.47836404 |
| 53 | Short hallux (HP:0010109) | 2.47790585 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.47242311 |
| 55 | Pulmonary artery stenosis (HP:0004415) | 2.46631982 |
| 56 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.46559227 |
| 57 | Adactyly (HP:0009776) | 2.46167917 |
| 58 | Obstructive sleep apnea (HP:0002870) | 2.44769895 |
| 59 | Neck muscle weakness (HP:0000467) | 2.43410355 |
| 60 | Hyperlipoproteinemia (HP:0010980) | 2.42838978 |
| 61 | Portal hypertension (HP:0001409) | 2.41097265 |
| 62 | Aortic aneurysm (HP:0004942) | 2.40557820 |
| 63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39169594 |
| 64 | Wrist flexion contracture (HP:0001239) | 2.39094642 |
| 65 | Arterial tortuosity (HP:0005116) | 2.38743565 |
| 66 | Abnormality of the ischium (HP:0003174) | 2.38004241 |
| 67 | Difficulty climbing stairs (HP:0003551) | 2.33992586 |
| 68 | Spinal rigidity (HP:0003306) | 2.32852678 |
| 69 | Venous insufficiency (HP:0005293) | 2.31428941 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30763418 |
| 71 | Oligomenorrhea (HP:0000876) | 2.30464007 |
| 72 | Prolonged QT interval (HP:0001657) | 2.29462729 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.28145419 |
| 74 | Subaortic stenosis (HP:0001682) | 2.28118398 |
| 75 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.28118398 |
| 76 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.26730346 |
| 77 | Venous abnormality (HP:0002624) | 2.23583543 |
| 78 | Heart block (HP:0012722) | 2.23550490 |
| 79 | Premature rupture of membranes (HP:0001788) | 2.22497046 |
| 80 | Eczematoid dermatitis (HP:0000976) | 2.21839233 |
| 81 | Aortic dissection (HP:0002647) | 2.21046752 |
| 82 | Porencephaly (HP:0002132) | 2.20170423 |
| 83 | Colitis (HP:0002583) | 2.20115312 |
| 84 | Absent hand (HP:0004050) | 2.19821275 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 2.19395328 |
| 86 | Muscle fiber inclusion bodies (HP:0100299) | 2.19258797 |
| 87 | Stroke (HP:0001297) | 2.18369658 |
| 88 | Palpitations (HP:0001962) | 2.15959474 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.15705024 |
| 90 | Striae distensae (HP:0001065) | 2.15512224 |
| 91 | Aortic valve stenosis (HP:0001650) | 2.14990103 |
| 92 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13946261 |
| 93 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.13654616 |
| 94 | Aortic regurgitation (HP:0001659) | 2.13269870 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12868377 |
| 96 | Abnormality of the hepatic vasculature (HP:0006707) | 2.12680286 |
| 97 | Neonatal death (HP:0003811) | 2.12347948 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.11306021 |
| 99 | Rhabdomyolysis (HP:0003201) | 2.11248782 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10636677 |
| 101 | Myotonia (HP:0002486) | 2.10629697 |
| 102 | Axonal loss (HP:0003447) | 2.09271832 |
| 103 | Acanthosis nigricans (HP:0000956) | 2.08723098 |
| 104 | Shallow orbits (HP:0000586) | 2.08541867 |
| 105 | Muscle stiffness (HP:0003552) | 2.06345435 |
| 106 | Myositis (HP:0100614) | 2.06325135 |
| 107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05561688 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05561688 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05561688 |
| 110 | Mucosal telangiectasiae (HP:0100579) | 2.04910597 |
| 111 | Distal lower limb muscle weakness (HP:0009053) | 2.02976956 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02813106 |
| 113 | Skull defect (HP:0001362) | 2.02346019 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 2.01803758 |
| 115 | Type 1 muscle fiber predominance (HP:0003803) | 2.01191988 |
| 116 | Mucopolysacchariduria (HP:0008155) | 2.00269929 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00269929 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.99538693 |
| 119 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.99230935 |
| 120 | Nemaline bodies (HP:0003798) | 1.99076890 |
| 121 | Ectopia lentis (HP:0001083) | 1.98196757 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.94839433 |
| 123 | EMG: neuropathic changes (HP:0003445) | 1.94159444 |
| 124 | Complement deficiency (HP:0004431) | 1.92610258 |
| 125 | Microcytic anemia (HP:0001935) | 1.92185019 |
| 126 | Bulbar palsy (HP:0001283) | 1.91992871 |
| 127 | Emphysema (HP:0002097) | 1.91586094 |
| 128 | Tetraparesis (HP:0002273) | 1.90582414 |
| 129 | Dysostosis multiplex (HP:0000943) | 1.90082876 |
| 130 | Bundle branch block (HP:0011710) | 1.89752877 |
| 131 | Mitral valve prolapse (HP:0001634) | 1.89635708 |
| 132 | Ventricular arrhythmia (HP:0004308) | 1.87383628 |
| 133 | Amyloidosis (HP:0011034) | 1.86470992 |
| 134 | Vascular tortuosity (HP:0004948) | 1.84564988 |
| 135 | Facial diplegia (HP:0001349) | 1.83712629 |
| 136 | Pulmonary embolism (HP:0002204) | 1.83514880 |
| 137 | Hemoptysis (HP:0002105) | 1.82392988 |
| 138 | Pulmonary hypertension (HP:0002092) | 1.82194216 |
| 139 | Lymphedema (HP:0001004) | 1.80789500 |
| 140 | Abnormality of the foot musculature (HP:0001436) | 1.80259279 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.80195971 |
| 142 | Chondrocalcinosis (HP:0000934) | 1.79611708 |
| 143 | Skin nodule (HP:0200036) | 1.79437834 |
| 144 | Xanthomatosis (HP:0000991) | 1.78852119 |
| 145 | Nuclear cataract (HP:0100018) | 1.78089554 |
| 146 | Hip contracture (HP:0003273) | 1.76909319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.26099519 |
| 2 | TGFBR2 | 3.33016298 |
| 3 | BLK | 2.23761262 |
| 4 | MAP3K6 | 2.10979351 |
| 5 | TTN | 2.10200808 |
| 6 | TGFBR1 | 2.07393363 |
| 7 | TIE1 | 12.0598418 |
| 8 | RIPK1 | 1.94145507 |
| 9 | GRK1 | 1.91122628 |
| 10 | CDC42BPA | 1.90780423 |
| 11 | ERN1 | 1.80276551 |
| 12 | NTRK2 | 1.79076655 |
| 13 | MYLK | 1.63959869 |
| 14 | FES | 1.61976138 |
| 15 | EPHB2 | 1.60562811 |
| 16 | RIPK4 | 1.59416632 |
| 17 | PTK2B | 1.56153352 |
| 18 | TRIB3 | 1.49530956 |
| 19 | DDR2 | 1.46261234 |
| 20 | CAMK1D | 1.41232107 |
| 21 | KIT | 1.40561212 |
| 22 | TNK2 | 1.38867691 |
| 23 | PKN2 | 1.33777590 |
| 24 | ZAP70 | 1.33527786 |
| 25 | MARK2 | 1.30763466 |
| 26 | CAMK1G | 1.22529639 |
| 27 | EPHB1 | 1.20682973 |
| 28 | DMPK | 1.17245874 |
| 29 | PDK2 | 1.14566669 |
| 30 | MAP2K3 | 1.11055702 |
| 31 | TEC | 1.08931179 |
| 32 | BMX | 1.03879802 |
| 33 | PTK6 | 1.03786947 |
| 34 | FGFR4 | 1.00754604 |
| 35 | BCKDK | 0.99670689 |
| 36 | MAP3K13 | 0.98706334 |
| 37 | PDGFRA | 0.96735457 |
| 38 | FER | 0.94302630 |
| 39 | LMTK2 | 0.87977452 |
| 40 | MAPK12 | 0.87380995 |
| 41 | PIK3CG | 0.86155923 |
| 42 | MAP3K3 | 0.86111043 |
| 43 | OBSCN | 0.81700022 |
| 44 | HCK | 0.80746864 |
| 45 | PHKG2 | 0.80742385 |
| 46 | PHKG1 | 0.80742385 |
| 47 | RPS6KL1 | 0.80469955 |
| 48 | RPS6KC1 | 0.80469955 |
| 49 | PRKG2 | 0.80285250 |
| 50 | RPS6KA2 | 0.79642351 |
| 51 | INSRR | 0.78537476 |
| 52 | MAP2K6 | 0.75510421 |
| 53 | HIPK2 | 0.75463548 |
| 54 | PRKD1 | 0.75442586 |
| 55 | BTK | 0.73836651 |
| 56 | PRKAA2 | 0.73345986 |
| 57 | RPS6KA6 | 0.72674917 |
| 58 | JAK1 | 0.72604699 |
| 59 | CAMK4 | 0.71277350 |
| 60 | SIK1 | 0.71124168 |
| 61 | PRPF4B | 0.69581664 |
| 62 | GRK5 | 0.63263487 |
| 63 | PIK3CA | 0.62751214 |
| 64 | PAK4 | 0.60056315 |
| 65 | EPHA3 | 0.56902746 |
| 66 | IKBKE | 0.56129463 |
| 67 | CSK | 0.55275199 |
| 68 | PRKCH | 0.52813869 |
| 69 | LRRK2 | 0.52441127 |
| 70 | PDK3 | 0.52057669 |
| 71 | PDK4 | 0.52057669 |
| 72 | SYK | 0.51379040 |
| 73 | MUSK | 0.50349653 |
| 74 | GRK6 | 0.48740141 |
| 75 | FGFR3 | 0.48344063 |
| 76 | DAPK2 | 0.48106584 |
| 77 | LATS1 | 0.47787631 |
| 78 | MOS | 0.47631013 |
| 79 | EEF2K | 0.47178110 |
| 80 | TRPM7 | 0.46900882 |
| 81 | PTK2 | 0.46781239 |
| 82 | MAP3K11 | 0.46000969 |
| 83 | MAP2K2 | 0.42897997 |
| 84 | TAOK1 | 0.42802391 |
| 85 | AKT3 | 0.42060692 |
| 86 | MAPKAPK3 | 0.41183614 |
| 87 | MAP3K7 | 0.40014165 |
| 88 | PDK1 | 0.39394864 |
| 89 | TBK1 | 0.38970727 |
| 90 | MAPK7 | 0.38839742 |
| 91 | MAP3K14 | 0.38723823 |
| 92 | JAK2 | 0.38551416 |
| 93 | PDPK1 | 0.38084060 |
| 94 | TESK1 | 0.37723128 |
| 95 | JAK3 | 0.37594285 |
| 96 | MAPK15 | 0.37013912 |
| 97 | ROCK2 | 0.36573379 |
| 98 | SGK2 | 0.36309620 |
| 99 | LCK | 0.36175608 |
| 100 | ILK | 0.36052355 |
| 101 | STK38 | 0.35938185 |
| 102 | MET | 0.35178419 |
| 103 | PRKCE | 0.33752082 |
| 104 | MAP3K1 | 0.33074579 |
| 105 | FLT3 | 0.32907570 |
| 106 | STK10 | 0.32414224 |
| 107 | PRKAA1 | 0.31450478 |
| 108 | IGF1R | 0.31033083 |
| 109 | ROCK1 | 0.30631777 |
| 110 | PAK3 | 0.30584727 |
| 111 | EGFR | 0.30319618 |
| 112 | TYK2 | 0.29497758 |
| 113 | GSK3A | 0.29245124 |
| 114 | PRKD3 | 0.28149296 |
| 115 | NEK9 | 0.27890068 |
| 116 | FGFR2 | 0.27670916 |
| 117 | PRKD2 | 0.27528294 |
| 118 | SRC | 0.27501959 |
| 119 | PDGFRB | 0.27301981 |
| 120 | MAP2K1 | 0.27114631 |
| 121 | RET | 0.26359438 |
| 122 | ICK | 0.26107222 |
| 123 | MTOR | 0.25545976 |
| 124 | PAK2 | 0.23851893 |
| 125 | LATS2 | 0.23672750 |
| 126 | MAP4K1 | 0.22907369 |
| 127 | NLK | 0.21986181 |
| 128 | MAP3K10 | 0.21380914 |
| 129 | CAMK1 | 0.19227982 |
| 130 | MAPK4 | 0.18208397 |
| 131 | PINK1 | 0.18142735 |
| 132 | SGK3 | 0.16828238 |
| 133 | ITK | 0.16675824 |
| 134 | INSR | 0.13840011 |
| 135 | MARK3 | 0.13557077 |
| 136 | FGFR1 | 0.13488512 |
| 137 | STK24 | 0.13048107 |
| 138 | GRK7 | 0.12631709 |
| 139 | DAPK3 | 0.12181303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.53909257 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47448332 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.42726569 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32487115 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30539245 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.24042677 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.19738696 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.18972222 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17826962 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11901851 |
| 11 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.09608032 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05497874 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.94436069 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93212183 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86440014 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74297091 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.74061561 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.68614515 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.66022177 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64165793 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.63423620 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63207824 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60027961 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51521491 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46769161 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45407775 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36550417 |
| 28 | * Bile secretion_Homo sapiens_hsa04976 | 1.32841073 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.30298518 |
| 30 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.22877606 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22760502 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20625923 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17538918 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16537619 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16087805 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.12739951 |
| 37 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.10647392 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07865882 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07860497 |
| 40 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.07739990 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06899828 |
| 42 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06553115 |
| 43 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05916587 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.05703325 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05041355 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03072194 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02960627 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01867484 |
| 49 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.01292856 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00420799 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99945020 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99433093 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99379648 |
| 54 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98914700 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98772079 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98530770 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95402912 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94890066 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.93544352 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92226601 |
| 61 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91612955 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89915310 |
| 63 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87568677 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87024966 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86883765 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85715411 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84519016 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84364257 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83990899 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82999191 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.82818112 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.82016808 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81671311 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.80754186 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80152909 |
| 76 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79455474 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78486662 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76401722 |
| 79 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76274022 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75316031 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.74891419 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74246490 |
| 83 | * Platelet activation_Homo sapiens_hsa04611 | 0.72257053 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71934462 |
| 85 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71809079 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71290098 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70061588 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69981085 |
| 89 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69842216 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69102422 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67599828 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66934808 |
| 93 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65877164 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65588343 |
| 95 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65285651 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64235944 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63449532 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63231702 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62592766 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62273854 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61478308 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61206148 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.61187870 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61036725 |
| 105 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59308247 |
| 106 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58790163 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57938822 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57786126 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57529638 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.56908347 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56597620 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55812564 |
| 113 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.55717938 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54707067 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54298067 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53964969 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52290746 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51998770 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51598252 |
| 120 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.50689885 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50564867 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50225704 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49561750 |
| 124 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.49058345 |
| 125 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46838299 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | 0.46779127 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46558709 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46270897 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45091544 |
| 130 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44979991 |
| 131 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44675048 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.44174992 |
| 133 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.43684059 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.43241914 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41792600 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.38059648 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35619684 |
| 138 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35564172 |
| 139 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35460014 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35060628 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.34694821 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34440998 |
| 143 | Endocytosis_Homo sapiens_hsa04144 | 0.33137482 |
| 144 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31656782 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30651873 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29955803 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29754222 |

